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accompanied by malnutrition is heart failure (HF). 
Advanced HF is often associated with severe mus‑
cle wasting, called cardiac cachexia, which conse‑
quently affects the disease course and significant‑
ly decreases the quality of life and survival in pa‑
tients with HF.5 In everyday practice, nutrition‑
al status is assessed by means of the body mass 
index (BMI); however, BMI does not distinguish 
between fat and lean body mass. In HF, even pa‑
tients without cardiac decompensation have ex‑
cess fluid compared with a standard healthy indi‑
vidual6; therefore, some patients who are regard‑
ed as having normal body weight may, in fact, be 
INTRODUCTION The problem of malnutrition, 
a risk factor for increased morbidity and reduced 
quality of life, is often underestimated in the ge‑
riatric population.1,2 In general, the term “malnu‑
trition” refers to an improper balance in catabol‑
ic and anabolic metabolism reactions and to pro‑
tein–energy malnutrition.3 According to the re‑
cent guidelines of the European Society of Clini‑
cal Nutrition and Metabolism, the term should be 
treated as a synonym for undernutrition.4 It may 
be a result of long ‑lasting chronic conditions, es‑
pecially in advanced age, and in patients with mul‑
tiple chronic conditions. One of the diseases often 
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ABSTRACT
INTRODUCTION An inverse relationship between natriuretic peptides (N ‑terminal fragment of the prohormone 
brain natriuretic peptide [NT ‑proBNP]) and body mass index (BMI) among healthy people and patients 
with chronic heart failure (CHF) was observed.
OBJECTIVES The aim of the study was to assess the relationship between nutritional status and NT‑
‑proBNP concentrations in older persons.
PATIENTS AND METHODS NT ‑proBNP concentrations, medical histories, and malnutrition risk using 
Mini Nutritional Assessment were evaluated. Body composition was measured with dual energy X ‑ray 
absorptiometry. The relationship of nutritional status with NT ‑proBNP concentrations (in tertiles) was 
assessed.
RESULTS The mean (SD) age of 106 participants was 72.16 (9.38) years. Heart failure was diagnosed 
in 72.6% of patients. The risk of malnutrition was recognized in 28.3%, and the percentage of patients 
at risk increased in subsequent NT ‑proBNP tertiles: from 16.7% in the first tertile to 48.6% in the third 
tertile (P = 0.005). The risk of malnutrition was associated with an increase in NT ‑proBNP concentra‑
tions per tertile (odds ratio [OR], 2.30; 95% CI, 1.30–4.07; P = 0.004). Based on a multivariable logistic 
model, the NT ‑proBNP concentration in the third tertile was associated with an over 9 ‑fold higher risk 
of malnutrition (OR, 9.80; 95% CI, 2.00–48.17; P = 0.005) as compared with the lowest concentration. 
Among patients with CHF, the relationship between NT ‑proBNP and nutritional status was even stronger.
CONCLUSIONS High NT ‑proBNP levels contribute to increased risk of malnutrition in older patients with 
heart failure. In patients with elevated NT ‑proBNP levels, the risk of malnutrition should be assessed.
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The exclusion criteria were as follows: Mini 
Mental State Examination (MMSE) score below 
10 and immobility. If the patient had cognitive 
impairment or dementia, the interview was com‑
pleted by a proxy.
In all patients, demographic data, smoking sta‑
tus, and medical history of chronic conditions 
and medications were obtained using a struc‑
tured questionnaire. The obtained data was sup‑
plemented in accordance with the medical docu‑
mentation. Height (m) and weight (kg) were mea‑
sured and BMI (kg/m2) was calculated according 
to the formula: weight (kg)/height (m2).
The risk of malnutrition was assessed using 
the MNA with a maximal score of 30 points and 
a score of 24 or higher suggesting normal nutri‑
tional status; scores between 17 and 23.5 indi‑
cated a risk of malnutrition, and below 17, mal‑
nutrition.31 Due to a low number of malnour‑
ished persons with an MNA score of less than 
17 in the analysis, we combined the group of in‑
dividuals with the score of less than 17 with those 
at risk of malnutrition (17–23.5 points); there‑
fore, the MNA score of less than 24 was used as 
the categorical variable.
Cognitive performance was evaluated using 
the MMSE, in which a score below 24 of 30 sug‑
gests cognitive impairment.32 Mood was as‑
sessed with the 30 ‑point Geriatric Depression 
Scale (GDS), in which a score above 9 points gives 
a suspicion of depression.33
Functional status was assessed by the Instru‑
mental Activities of Daily Living (IADL) scale, 
with a maximum score of 27 points and the as‑
sumption that the higher the score the better 
the functional status.34 The Katz Index of Activ‑
ities of Daily Living was also used for functional 
status assessment, with the score ranging from 
0 to 6 and interpreted as follows: 5 to 6 points, 
people efficient in basic self ‑service; 3 to 4 points, 
moderately disabled; and 0 to 2 points, severe‑
ly disabled.35
Chronic kidney disease was defined as an es‑
timated glomerular filtration rate (eGFR) below 
60 ml/min/1.73 m2, according to the Modifica‑
tion of Diet in Renal Disease formula.
Left ventricular ejection fraction was measured 
by transthoracic echocardiography (Toshiba Xario 
XG, Japan) with a 2.5‑ to 3.5 ‑MHz probe.
The body composition including total lean body 
mass, appendicular lean mass, and body fat (total, 
trunk, and appendicular body fat) was examined 
using dual energy X ‑ray absorptiometry (Lunar 
Prodigy, General Electric Medical Systems Mad‑
ison Wisconsin, United States).
A serum NT ‑proBNP level was measured by 
an  electrochemiluminescence immunoassay 
method (NT ‑proBNP, Roche Diagnostics GmbH, 
Germany, Mannheim) with a Roche immunoas‑
say analyzer.
The study was approved by the Bioethical Com‑
mittee of Jagiellonian University (Kraków, Po‑
land). All subjects signed an informed consent 
to participate in the study.
underweight. It is important to identify patients 
who are at risk because malnutrition is largely ir‑
reversible, especially in the elderly. In the latest 
research,7 it was shown that all ‑cause mortality 
was minimal in a BMI range of 20.0 to 25.0 kg/m2, 
and it was significantly increased just below this 
range. In older age groups, the lowest mortality was 
found at a slightly higher BMI than in younger age 
groups. Moreover, in patients with acute or sta‑
ble HF, a higher BMI was strongly associated with 
decreased mortality.8,9 This phenomenon is called 
“reverse epidemiology” or “obesity paradox”.10,11
Several published studies have documented 
an inverse relationship between BMI and markers 
of HF, including brain natriuretic peptides (BNPs) 
and N ‑terminal fragment of the prohormone BNP 
(NT ‑proBNP)12-14; these markers are used to as‑
sess the presence and severity of HF. The inverse 
relationship was observed among healthy people, 
patients with an acute chronic HF (CHF) exacer‑
bation, and patients with stable, well ‑controlled 
CHF.15,16 Obese patients have reduced concentra‑
tions of BNP and NT ‑proBNP, compared with non‑
obese ones, despite having elevated left ventricu‑
lar end ‑diastolic pressure.17 Although BNP and NT‑
‑proBNP levels are relatively lower in overweight 
and obese patients with HF, increased concentra‑
tions predict worse symptoms, impaired hemody‑
namics, and higher mortality at all BMI levels.18
Thus far, the relationship between BNP levels 
and malnutrition–inflammation syndrome was 
mainly assessed in patients with end ‑stage re‑
nal disease. In this chronic condition, the associ‑
ation of elevated BNP levels with left ventricular 
hypertrophy and increased risk of death has been 
extensively studied.19,20 Recently, Di Marca et al21 
showed that increased BNP levels, along with mal‑
nutrition and chronic kidney disease, predict 30‑
‑day mortality after discharge in elderly patients 
with diagnosis on admission other than HF. Espe‑
cially in the hemodialysis population, natriuretic 
peptides are considered to be potential malnutri‑
tion biomarkers.18,22-28 Moreover, in patients with 
systemic sclerosis,29 high NT ‑proBNP levels were 
associated with reduced nutritional status. To 
our knowledge, only one study assessed nutri‑
tional status using the Mini Nutritional Assess‑
ment (MNA) screening score and found a signif‑
icant inverse correlation between the score and 
NT ‑proBNP levels in patients with systolic HF.30
We aimed to further explore the association 
between NT ‑proBNP levels and nutritional sta‑
tus in elderly patients with multiple chronic con‑
ditions. We also examined the relationship be‑
tween NT ‑proBNP levels and risk of malnutri‑
tion in this population.
PATIENTS AND METHODS Study design and patient 
enrollment The study had a cross ‑sectional design. 
Patients aged 60 years or older followed in the Ge‑
riatric Outpatient Clinic of the University Hospi‑
tal in Kraków, Poland, who agreed to participate 
in the study and signed informed consent, were 
included from October 2010 to February 2014.
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The groups did not differ in terms of age, 
smoking status, amount of lean body mass; 
MNA, MMSE, and GDS results; or history of 
myocardial infarction, stroke, and diabetes mel‑
litus. Higher NT ‑proBNP levels were correlated 
with an increased number of patients diagnosed 
with CHF, coronary heart disease (CHD), and hy‑
pertension; in contrast, there was a decreased 
percentage of female participants. The  risk 
of malnutrition was observed in 30 patients 
(28.3%) (women, 54.6%; men, 25%). In subse‑
quent NT ‑proBNP tertiles, higher NT ‑proBNP 
levels were associated with an increased likeli‑
hood of being malnourished.
BMI and total body fat decreased with an in‑
creasing NT ‑proBNP level (per tertile) (P = 
0.02 and P <0.001, respectively). Negative cor‑
relations between NT ‑proBNP levels and BMI 
(r = –0.19; P = 0.048), body fat amount (r = –0.33; 
P = 0.005), and body fat percentage (r = –0.33; 
P = 0.049) were found. There was no correlation 
between NT ‑proBNP levels and lean body mass.
In a logistic regression analysis, the risk of 
malnutrition (MNA <24) was introduced as a de‑
pendent variable; the impact of potential predic‑
tors was assessed in crude (univariate) models 
(TABLE 2). The concomitant diseases (including hy‑
pertension [OR, 0.51; 95% CI, 0.15–1.74], CHD 
[OR, 0.88; 95% CI, 0.32–2.41], diabetes [OR, 1.25; 
95% CI, 0.52–3.04], and CHF [OR, 1.74; 95% CI, 
0.63–4.81]) were not associated with the risk of 
malnutrition.
The risk of malnutrition, defined as an MNA 
score of less than 24, was over 4 ‑fold higher in 
patients in the third tertile of NT ‑proBNP lev‑
els in comparison with those in the first tertile 
(TABLE 2). The trend was significant in the analysis 
of the entire group. In the crude analysis, an in‑
crease in NT ‑proBNP concentrations (per tertile) 
was associated with an over 2 ‑fold increase in 
the risk of malnutrition (OR, 2.30; 95% CI, 1.30–
4.07; P = 0.004).
With an increase of the NT ‑proBNP level by 
100 pg/ml, the risk of malnutrition increased 
by 2% (OR, 1.02; 95% CI, 1.01–1.04; P = 0.009).
Further analysis, with adjustment for oth‑
er confounders (age, IADL, MMSE, number of 
chronic diseases, chronic kidney disease, and HF), 
confirmed the relationship between the tertiles of 
NT ‑proBNP levels and risk of malnutrition. This 
analysis also revealed the protective role of bet‑
ter cognitive performance, represented by a high‑
er MMSE score (TABLE 3).
A separate analysis for patients with HF (n = 
76) and those without (n = 29) was also per‑
formed. The relationship (adjusted for age, chron‑
ic kidney disease, IADL, MMSE, number of chron‑
ic diseases) remained significant only in the HF 
group. In comparison with patients in the first 
tertile of NT ‑proBNP concentrations, the risk of 
malnutrition was much higher (OR, 26.2; 95% 
CI, 2.12–324.28) in patients in the third tertile 
(TABLE 4).
Statistical analysis Statistical analysis was carried 
out using Stata/SE 14 (Stata Corp, College Station, 
Texas, United States). The results were present‑
ed as mean (SD) or as frequency and percentag‑
es for nominal variables. Patients were divided 
into 3 groups according to the tertiles of plasma 
NT ‑proBNP concentrations. The mean values for 
continuous variables in these groups were com‑
pared using 1 ‑way analysis of variance and per‑
centages for nominal variables using the χ2 test. 
In addition, to assess the association between 
NT ‑proBNP levels and continuous predictors, 
the Spearman correlation was used.
The impact of selected predictors on the risk 
of malnutrition was analyzed by logistic regres‑
sion models. First, the univariate logistic regres‑
sion models were built to assess the crude (un‑
standardized) odds ratios (ORs) for the relation‑
ship between the studied variable and the risk of 
malnutrition. Next, in the multivariable logistic 
regression model, the effect of the MMSE score 
(as a significant predictor in the univariate mod‑
el) and a set of confounders based on literature 
(ie, chronic kidney disease, age, functional sta‑
tus [IADL], CHF, and a number of chronic dis‑
eases) on the relationship between NT ‑proBNP 
tertiles and malnutrition was assessed. Addi‑
tionally, we analyzed the effect of NT ‑proBNP on 
malnutrition risk using a model with NT ‑proBNP 
as a continuous variable (expressed per 100 pg/
ml). An additional analysis was performed to as‑
sess the relationship between NT ‑proBNP levels 
and malnutrition risk in the group of patients 
with HF. The results were adjusted for the same 
set of independent variables as in the whole 
group. In all statistical analyses, 2 ‑sided tests 
were used. P values of less than 0.05 were con‑
sidered significant.
RESULTS The mean (SD) age of 106 individuals 
(men, 58.5%) was 72.16 (9.38) years. The mean 
(SD) number of chronic conditions was 5.6 (2.5) 
and the mean (SD) number of medications was 
7.15 (2.5). The mean (SD) IADL and ADL scores 
in the whole study group were 23.65 (3.60) and 
5.90 (0.45), respectively. CHF was diagnosed in 
77 patients (72.64%). Most of them (57.14%) 
were in New York Heart Association class III, 
while 33.77% were in class II. Most patients re‑
ceived standard therapy with an angiotensin‑
‑converting enzyme inhibitor (or sartan), diuret‑
ic, and β ‑blocker. No patient presented with overt 
symptoms of HF during the study.
In the whole group, a negative correlation be‑
tween the MNA score and NT ‑proBNP levels was 
found (r = –0.23; P = 0.02). Due to its skewed 
distribution, NT ‑proBNP concentrations were 
divided into tertiles; the relationship between 
NT ‑proBNP ranges within each tertile and MNA 
scores were further assessed. The baseline char‑
acteristics of the study population, stratified by 
tertiles of NT ‑proBNP concentrations, are pre‑
sented in TABLE 1.
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Other studies examining chronic diseases such 
as systemic sclerosis29 and HF,14,30,36,37 as well 
as population ‑based studies,13,38 were also con‑
ducted. The finding concerning the inverse re‑
lationship between BMI and NT ‑proBNP levels 
remains in line with the results of other autho
rs.13-17,22,25,30,38-41
In contrast to the previous research,13,14 how‑
ever, our study shows an inverse association be‑
tween NT ‑proBNP and fat mass (not lean mass). 
In comparison with younger populations in some 
previous studies,13,14,42 our study population was 
older with a mean (SD) age of 72.16 (9.38) years. 
We should consider frequent multimorbidity and 
chronic inflammatory diseases in our patients, 
which might influence and intensify different 
physiologic age ‑related changes. A negative cor‑
relation between NT ‑proBNP and fat mass was 
also shown by Christensen et al,37 although in 
their prospective study fat mass increased dur‑
ing follow ‑up. This phenomenon may be related to 
the lipolytic role of natriuretic peptides through 
activation of the hormone sensitive lipase,43 as 
well as to an increase in energy utilization and 
thermogenesis by enhancing browning of white 
adipocytes.44
DISCUSSION The main finding of our study, 
apart from the  inverse relationship between 
NT ‑proBNP concentrations and MNA score, was 
the degree of malnutrition risk associated with 
increasing NT ‑proBNP levels. There was an over 
2 ‑fold higher risk of malnutrition with an in‑
crease of NT ‑proBNP levels per tertile and an over 
9 ‑fold higher risk in patients with the highest 
NT ‑proBNP level. Furthermore, in patients with 
CHF, the higher NT ‑proBNP level was associat‑
ed with a 26 ‑fold higher risk of malnutrition for 
those in the third tertile (after controlling for dif‑
ferent confounders).
Additionally, there were negative correlations 
between NT ‑proBNP levels and BMI, body fat 
amount, and body fat percentage; however, there 
were no correlations between NT ‑proBNP levels 
and lean body mass.
Our study examining patients with HF dem‑
onstrated a significant relationship between NT‑
‑proBNP levels and the risk of malnutrition, an as‑
sociation that was also found in studies examining 
other groups, also patients without HF. The ob‑
servation of an inverse relationship between nu‑
tritional status and BNPs mainly come from stud‑
ies in patients with end ‑stage renal disease.18,22-28 
TABLE 1 Characteristics of the study group stratified by tertiles of N ‑terminal fragment of the prohormone brain 
natriuretic peptide concentrations
Variable Tertiles of NT ‑proBNP level, pg/ml P value
1st (n = 36) 2nd (n = 35) 3rd (n = 35)
<268.4 268.4–1339.0 >1339.0
Age, y, mean (SD) 71.3 (7.6) 73.9 (9.98) 71.3 (10.39) 0.43a
Sex, women, n (%) 22 (61.1) 16 (45.7) 6 (17.1) 0.001b
Smoking, n (%) 3 (8.6) 4 (11.4) 6 (17.1) 0.54b
CHF, n (%) 13 (36.1) 29 (82.9) 35 (100.0) <0.001b
CHD, n (%) 21 (58.3) 31 (88.6) 31 (88.6) 0.002b
Arterial hypertension, n (%) 28 (77.8) 32 (91.4) 34 (97.1) 0.03b
Myocardial infarction, n (%) 12 (33.3) 16 (45.7) 20 (57.1) 0.13b
Stroke, n (%) 4 (11.1) 2 (5.7) 3 (8.6) 0.72b
Diabetes, n (%) 11 (30.6) 12 (34.3) 12 (34.3) 0.93b
MNA, points, mean (SD) 25.7 (2.72) 25.4 (2.65) 24.4 (2.73) 0.10a
BMI, kg/m2, mean (SD) 29.6 (4.65) 27.8 (4.43) 26.7 (3.81) 0.02a
Chronic kidney disease, n (%) 5 (13.9) 9 (25.7) 11 (32.4) 0.18b
MNA score <24, n (%) 6 (16.7) 7 (20.0) 17 (48.6) 0.005b
MMSE, points, mean (SD) 26.9 (2.81) 26.6 (3.82) 27.0 (2.93) 0.85a
GDS, points, mean (SD) 9.7 (6.44) 9.6 (5.84) 9.4 (5.13) 0.98a
IADL, points, mean (SD) 23.8 (3.61) 24.3 (3.04) 22.9 (4.06) 0.27a
ADL, points, mean (SD) 5.8 (0.71) 5.9 (0.24) 6.0 (0.19) 0.29a
Creatinine, µmol/l, mean (SD) 76.2 (21.98) 90.5 (29.61) 104.6 (36.27) <0.001a
Appendicular lean mass, kg, mean (SD) 20.4 (4.26) 19.3 (3.48) 21.5 (4.06) 0.10a
Lean body mass, kg, mean (SD) 47.6 (8.97) 46.0 (6.88) 50.2 (8.35) 0.13a
Total fat, kg, mean (SD) 41.0 (6.20) 34.6 (7.98) 31.1 (8.22) <0.001a
a Analysis of variance;  b χ2 test
Abbreviations: ADL, Activities of Daily Living; BMI, body mass index; CHD, coronary heart disease; CHF, chronic heart 
failure; GDS, Geriatric Depression Scale; IADL, Instrumental Activities of Daily Living; MMSE, Mini Mental State 
Examination; MNA, Mini Nutritional Assessment; NT ‑proBNP, N ‑terminal fragment of the prohormone brain natriuretic 
peptide
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a heart–gut–brain axis, which might play a cen‑
tral role in adapting appetite and energy homeo‑
stasis to the degree of heart dysfunction. Despite 
this, age ‑adjusted NT ‑proBNP cutoffs to “rule in” 
HF and age ‑independent cutoffs to “rule out” HF 
in patients with acute dyspnea are equally use‑
ful for obese and lean patients; an adjustment 
of NT ‑proBNP thresholds for BMI is not recom‑
mended.40 The NT ‑proBNP concentration retains 
its diagnostic and prognostic capacity across all 
BMI categories.25
The inverse correlation between NT ‑proBNP 
and BMI was also shown in individuals without 
CHF. Fragopoulou et al38 demonstrated, in their 
ATTICA study, that NT ‑proBNP values were posi‑
tively correlated with age and inversely with BMI, 
creatinine clearance, and hemoglobin values in 
an apparently healthy Greek population. A linear 
regression analysis revealed that sex was the main 
contributor of NT ‑proBNP levels, followed by age, 
BMI, and creatinine levels.
The problem of the association between NT‑
‑proBNP and malnutrition was mainly derived 
from research on patients with end ‑stage renal 
disease on hemodialysis. Lee et al25 concluded 
that malnutrition in hemodialysis patients is as‑
sociated with volume overload and increased log‑
‑transformed NT ‑proBNP levels independent of 
volume status, and these levels are further inde‑
pendently associated with an increased left ven‑
tricular mass index. This also suggests a possibil‑
ity that nutritional status may affect ventricular 
remodeling in hemodialysis patients.25 Anoth‑
er example is a study by Guo et al.24 They dem‑
onstrated the association between NT ‑proBNP 
and protein ‑energy wasting adjusted for age, di‑
alysis vintage, and inflammation (OR, 2.3; P = 
0.008), which may partly explain the strong re‑
lationship between NT ‑proBNP and mortality in 
hemodialyzed patients.24 In the study conduct‑
ed by Bednarek ‑Skublewska et al,23 NT ‑proBNP 
levels were elevated in patients with an intensive 
catabolism, severe anemia, higher mean arterial 
blood pressure, and longer duration of hemodi‑
alysis. Booth et al22 showed that NT ‑proBNP was 
not associated with cardiac dysfunction, as as‑
sessed by a transthoracic echocardiography and 
nuclear medicine scintigraphy, but depended on 
factors associated with volume overload. The au‑
thors emphasize that, because bioimpedance re‑
sults might be affected by malnutrition with a loss 
of cell mass, NT ‑proBNP levels may be elevated 
in people with malnutrition.22
Although nutritional status is assessed by BMI 
in everyday practice, this index does not distin‑
guish between fat and lean body mass. In their 
PLICA study, Gastelurrutia et al42 focused on 
the muscle wasting that accompanies CHF and 
concluded that nutritional status is a key prognos‑
tic factor above and beyond BMI and percentage 
of body fat. Patients in normal, overweight, and 
obese BMI ranges all experienced undernourish‑
ment. The high mortality observed in undernour‑
ishment, uncommon in patients with high BMI, 
On the other hand, lower concentrations of 
both BNP and NT ‑proBNP among patients with 
a higher BMI might be due to reduced synthe‑
sis or secretion of peptides, rather than an in‑
creased clearance. The results of a recently pub‑
lished study suggest that BNP may be involved 
in appetite regulation.45 Vila et al45 revealed that 
an intravenous administration of BNP reduces 
circulating ghrelin concentrations, decreases 
hunger, and increases the feeling of satiety in 
healthy people. This may support the existence of 
TABLE 2 Crude odds of malnutrition (Mini Nutritional Assessment score <24)a
Variable OR 95% CI P value
NT ‑proBNP, tertiles 1st 1.00 Ref. –
2nd 1.25 0.37–4.17 0.72
3rd 4.72 1.57–14.17 0.006
Age, y 1.01 0.97–1.06 0.58
Sex (women vs men) 1.62 0.69–3.80 0.27
Smoking (yes vs no) 0.72 0.18–2.83 0.64
CHF (yes vs no) 1.74 0.63–4.81 0.29
CHD (yes vs no) 0.88 0.32–2.41 0.80
Arterial hypertension (yes vs no) 0.51 0.15–1.74 0.28
Myocardial infarction (yes vs no) 1.30 0.56–3.04 0.54
Stroke (yes vs no) 1.30 0.30–5.56 0.73
Diabetes (yes vs no) 1.25 0.52–3.04 0.62
BMI, kg/m2 0.86 0.77–0.97 0.01
Chronic kidney disease (yes vs no) 1.24 0.47–3.28 0.66
MMSE, points 0.84 0.73–0.97 0.02
GDS, points 1.05 0.98–1.13 0.20
IADL, points 0.90 0.80–1.01 0.08
ADL, points 1.32 0.40–4.41 0.65
Creatinine, µmol/l 1.005 0.99–1.02 0.49
Appendicular lean mass, kg 0.96 0.85–1.07 0.45
Lean body mass, kg 0.97 0.92–1.03 0.36
Total fat, kg 0.98 0.92–1.04 0.51
a Based on the univariate logistic regression model
Abbreviations: OR, odds ratio; others, see TABLE 1
TABLE 3 Logistic regression model for the risk of malnutrition (Mini Nutritional 
Assessment score <24) (n = 105)
Characteristics OR 95% CI P value
NT ‑proBNP 1st 1.00 Ref. –
2nd 1.70 0.39–7.52 0.48
3rd 9.80 2.00–48.17 0.005
Age 1.00 0.95–1.06 0.88
Chronic kidney disease (yes vs no) 1.18 0.35–3.91 0.79
IADL 0.96 0.84–1.10 0.57
MMSE 0.82 0.70–0.97 0.02
No. of diseasesa 1.17 0.75–1.83 0.50
CHF (yes vs no) 0.29 0.05–1.85 0.19
a Chronic heart failure, coronary heart disease, myocardial infraction, stroke, valvular 
heart disease, diabetes, arthritis
Abbreviations: see TABLES 1 and 2
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is the fact that we defined CHF by clinical symp‑
toms and an ejection fraction; we did not assess 
diastolic function of the heart. Therefore, higher 
NT ‑proBNP levels in patients without diagnosis 
or symptoms of HF may be due to long ‑term hy‑
pertension, medications, or compensated CHF. 
In the latter, the patient would be asymptomat‑
ic despite increased plasma BNP and NT ‑proBNP 
concentrations.
Finally, the number of patients in the groups 
with and without HF was uneven, with fewer par‑
ticipants in the group without defined HF.
In conclusion, high NT ‑proBNP levels contribute 
to increased risk of malnutrition in elderly patients 
with HF. Elderly patients with elevated NT ‑proBNP 
levels should be assessed for the risk of malnutri‑
tion. However, to confirm these findings and gain 
a more in ‑depth understanding of this issue, fur‑
ther research is needed to investigate the associat‑
ed mechanisms, the relationship between fat mass 
and lean body mass, the obesity paradox in elderly 
individuals with HF, and the possibility of improv‑
ing HF treatment to reduce the risk of malnutri‑
tion. In addition, the potential role of NT ‑proBNP 
as a good predictor of malnutrition risk assessed 
by the MNA needs to be explored.
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